90 related articles for article (PubMed ID: 21680534)
1. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.
Eissa S; Swellam M; El-Khouly IM; Kassim SK; Shehata H; Mansour A; Esmat M; Nossier AI; Hamdy MA; Awad NM; El-Ahmady O
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1657-64. PubMed ID: 21680534
[TBL] [Abstract][Full Text] [Related]
2. Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt.
Gaber DA; Wassef RM; El-Ayat WM; El-Moazen MI; Montasser KA; Swar SA; Amin HAA
Sci Rep; 2020 Nov; 10(1):18844. PubMed ID: 33139749
[TBL] [Abstract][Full Text] [Related]
3. Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.
Metwally NS; Ali SA; Mohamed AM; Khaled HM; Ahmed SA
Cancer Cell Int; 2011 Apr; 11(1):8. PubMed ID: 21473769
[TBL] [Abstract][Full Text] [Related]
4. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
[TBL] [Abstract][Full Text] [Related]
6. Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
Aine M; Sjödahl G; Eriksson P; Veerla S; Lindgren D; Ringnér M; Höglund M
Genome Med; 2015; 7(1):23. PubMed ID: 25810763
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.
Sacristan R; Gonzalez C; Fernández-Gómez JM; Fresno F; Escaf S; Sánchez-Carbayo M
J Mol Diagn; 2014 Sep; 16(5):564-572. PubMed ID: 24998186
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer.
Bilgrami SM; Qureshi SA; Pervez S; Abbas F
Springerplus; 2014; 3():178. PubMed ID: 24790823
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.
Beukers W; Hercegovac A; Vermeij M; Kandimalla R; Blok AC; van der Aa MM; Zwarthoff EC; Zuiverloon TC
J Urol; 2013 Jul; 190(1):311-6. PubMed ID: 23369722
[TBL] [Abstract][Full Text] [Related]
10. Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer.
Scher MB; Elbaum MB; Mogilevkin Y; Hilbert DW; Mydlo JH; Sidi AA; Adelson ME; Mordechai E; Trama JP
J Urol; 2012 Dec; 188(6):2101-7. PubMed ID: 23083854
[TBL] [Abstract][Full Text] [Related]
11. Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.
Zhao Y; Guo S; Sun J; Huang Z; Zhu T; Zhang H; Gu J; He Y; Wang W; Ma K; Wang J; Yu J
PLoS One; 2012; 7(4):e35175. PubMed ID: 22529986
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
Reinert T; Modin C; Castano FM; Lamy P; Wojdacz TK; Hansen LL; Wiuf C; Borre M; Dyrskjøt L; Orntoft TF
Clin Cancer Res; 2011 Sep; 17(17):5582-92. PubMed ID: 21788354
[TBL] [Abstract][Full Text] [Related]
13. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
[TBL] [Abstract][Full Text] [Related]
16. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
18. Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis.
Zhou Z; Guo Y; Liu Y; Zhang F; Wang Y; Shen B; Qin Y; Qiu J
Exp Cell Res; 2015 Feb; 331(2):399-407. PubMed ID: 25478998
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis.
Chen H; Yu Y; Rong S; Wang H
Biomarkers; 2014 May; 19(3):189-97. PubMed ID: 24693860
[TBL] [Abstract][Full Text] [Related]
20. A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence.
Su SF; de Castro Abreu AL; Chihara Y; Tsai Y; Andreu-Vieyra C; Daneshmand S; Skinner EC; Jones PA; Siegmund KD; Liang G
Clin Cancer Res; 2014 Apr; 20(7):1978-89. PubMed ID: 24691641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
